Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study
Author:
Affiliation:
1. Department of Veterinary Medicine; University of Cambridge, The Queen's Veterinary School Hospital; Cambridge UK
2. Department of Veterinary Medicine and Science; University Complutense of Madrid, Veterinary School Hospital; Madrid Spain
Publisher
Wiley
Subject
General Veterinary,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1136/vr.103398/fullpdf
Reference41 articles.
1. Long-term efficacy and safety of firocoxib in the treatment of dogs with osteoarthritis;AUTEFAGE;Veterinary Record,2011
2. Survival time of dogs with inflammatory mammary cancer treated with palliative therapy alone or palliative therapy plus chemotherapy;CLEMENTE;Veterinary Record,2009
3. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer;CLEMENTE;The Veterinary Journal,2013
4. Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment;DE SOUZA;The Canadian Veterinary Journal,2009
5. COX-2 expression in canine normal and neoplastic mammary gland;DIAS PEREIRA;Journal of Comparative Pathology,2009
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intensive Multimodal Chemotherapy in a Dog Suffering from Grade III/Stage IV Solid Mammary Carcinoma;Animals;2024-09-09
2. Canine Breast Carcinomas: Recent Advances in Diagnostic and Treatment Strategies;Advanced Therapeutics;2024-08-16
3. Effect of Melatonin on Chemoresistance Exhibited by Spheres Derived from Canine Mammary Carcinoma Cells;Animals;2024-04-19
4. Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies;International Journal of Molecular Sciences;2024-03-01
5. Hormone, Targeted, and Combinational Therapies for Breast Cancers: From Humans to Dogs;International Journal of Molecular Sciences;2024-01-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3